Category Archives: Pr Newswire

Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma

52% Amtagvi Response Rate with Two or Fewer Prior Lines of Therapy 73% Overall Disease Control Rate SAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced data […]

Renaissance Recovery’s Award-Winning Drug and Alcohol Rehab Center Launches New 10,000 Sq. Ft. Expansion in Nashville, Tennessee

NASHVILLE, Tenn., Feb. 05, 2026 (GLOBE NEWSWIRE) — Renaissance Recovery, a District Behavioral Health Group (DBH) company, announced today the opening of its newest expansion in Nashville, Tennessee. As an award-winning, growing provider of addiction recovery and mental health treatment services, Renaissance Recovery is thrilled to expand access to evidence-backed, compassionate treatment for individuals seeking […]

World’s First Serum-Free Iterative Rabies Vaccine from AIM Successfully Passes On-Site Registration Inspections and Is Imminent for Launch

HONG KONG, Feb. 6, 2026 /PRNewswire/ — Poised to Fill the Global Market Gap, the Serum-Free Iterative Rabies Vaccine Approaches a Critical Milestone in Commercialization. AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on February 5 that its wholly-owned subsidiary AIM Rongyu’s world’s first independently developed serum-free iterative rabies vaccine has successfully passed the […]

VARON Marks Valentine’s Day With Health-Focused Savings That Put Care First

Love looks like care. This Valentine’s Day, VARON invites families to show love in a way that helps loved ones breathe easier—at home and on the go. NEW YORK, Feb. 6, 2026 /PRNewswire/ — VARON, a trusted provider of respiratory care solutions, today announced its Valentine’s Day Sale, a limited-time event designed to celebrate love through […]

This Valentine’s Day, VARON Encourages Filipinos to Show Love Through Better Respiratory Health

MANILA, Philippines, Feb. 5, 2026 /PRNewswire/ — Valentine’s Day is traditionally associated with flowers and chocolates, but health experts encourage Filipinos to also prioritize well-being for themselves and their loved ones. Respiratory health is increasingly important as more people manage chronic conditions, recover from illness, or maintain active lifestyles amid environmental challenges. VARON Philippines marks the […]

Monport Positions Laser Engraving as a Growing Trend for Valentine’s Day Personalized Gifts

NEW YORK, Feb. 6, 2026 /PRNewswire/ — As Valentine’s Day approaches, Monport Laser is highlighting how desktop laser engravers, industrial CO2 laser engraver cutting machines, and fiber laser engravers are increasingly used for customized gifts and personalized products. The company’s Valentine’s Day Sale, running Feb. 5 through Feb. 16, 2026, combines reward points, sitewide discounts, and product-specific […]

MGM China Reports 2025 Annual Results

Revenue, Adjusted EBITDA and MarketshareContinued to Grow to All-Time High HONG KONG, Feb. 6, 2026 /PRNewswire/ — MGM China Holdings Limited (“MGM China” or the “Company”; SEHK Stock Code: 2282) today announced the selected unaudited financial data of the Company and its subsidiaries (the “Group”) for the 12 months ended December 31, 2025 (the “Year”). The […]

BioCryst to Report Fourth Quarter 2025 Financial Results on February 26

RESEARCH TRIANGLE PARK, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its fourth quarter 2025 financial results on Thursday, February 26, 2026. BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a […]

Climb Bio to Present at Upcoming Investor Conferences

WELLESLEY HILLS, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that members of its executive team will participate in the upcoming conferences detailed below. Guggenheim’s Emerging Outlook: Biotech SummitFormat: Fireside ChatDate: Thursday, February 12, 2026Time: 3:00 – […]

Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) — Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech […]